SERADA Satoshi 世良田聡

… Alternative Names

SERAD Satoshi 世良田聡

SERADA SATOSHI 世良田聡

Less

Researcher Number	50463302
Other IDs
Affiliation (Current)	2025: 岩手医科大学, 医歯薬総合研究所, 准教授 2025: 高知大学, 医学部, 特任准教授
Affiliation (based on the past Project Information) *help	2025: 岩手医科大学, 医歯薬総合研究所, 准教授 2021 – 2023: 岩手医科大学, 医歯薬総合研究所, 准教授 2020: 高知大学, 教育研究部医療学系臨床医学部門, 准教授 2016 – 2019: 高知大学, 医学部附属病院, 特任准教授 2015: 国立研究開発法人医薬基盤・健康・栄養研究所, 免疫シグナルプロジェクト, 研究員 … More 2015: 国立研究開発法人医薬基盤・健康・栄養研究所, 医薬基盤研究所免疫シグナルプロジェクト, 研究員 2011 – 2014: 独立行政法人医薬基盤研究所, 創薬基盤研究部, 研究員 2010: 独立行政法人医薬基盤研究所, 創薬基盤研究部免疫シグナルプロジェクト, 研究員 2009: National Institute of Biomedical Innovation, 基盤的研究部・免疫シグナルプロジェクト, 研究員 2008 – 2009: National Institute of Biomedical Innovation, 基盤的研究部免疫シグナルプロジェクト, 研究員 Less
Review Section/Research Field	Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related / Tumor therapeutics / Gastroenterology / Dermatology / Urology Except Principal Investigator Basic Section 52050:Embryonic medicine and pediatrics-related / Basic Section 56040:Obstetrics and gynecology-related / Basic Section 56050:Otorhinolaryngology-related / Dermatology / Tumor therapeutics
Keywords	Principal Investigator 癌 / 抗体 / Glypican-1 / 抗体医薬 / コンパニオン診断薬 / 食道癌 / 抗体療法 / 癌幹細胞 / 蛋白質 / タンパク質 … More / プロテオーム / Periostin / periostin / SOCS / サイトカイン … More Except Principal Investigator 重症気管支肺異形成 / バイオマーカー / 絨毛膜羊膜炎 / プロテオーム解析 / LRG / 遺伝子治療 / 頭頸部癌 / 癌遺伝子治療 / 蛋白質 / 抗体医薬 / 悪性黒色腫 / 抗体 / タンパク質 / プロテオーム / 癌 / 抗体療法 / LSR / 癌幹細胞 / 卵巣癌 Less

Glypican-1を標的とした新規抗体薬物複合体による化学療法抵抗性膵臓癌の克服Principal Investigator
- Principal Investigator
  
  世良田聡
- Project Period (FY)
  2025 – 2027
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Iwate Medical University
プロテオーム解析による、重症気管支肺異形成を予測する新規バイオマーカーの同定
- Principal Investigator
  
  外舘玄一朗
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 52050:Embryonic medicine and pediatrics-related
- Research Institution
  Iwate Medical University
Development of a companion diagnostics toward for Glypican-1 targeted antibody-based medicinePrincipal Investigator
- Principal Investigator
  
  世良田聡
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Iwate Medical University
抗癌剤の薬効を増強できる抗体を用いた抗体薬物複合体による卵巣癌治療薬
- Principal Investigator
  
  神田瑞希
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Iwate Medical University
An Experimental Stady for SOCS1 Gene Therapy in Head and Neck Cancers treatments
- Principal Investigator
  
  Komori Masahiro
- Project Period (FY)
  2020 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56050:Otorhinolaryngology-related
- Research Institution
  Kochi University
Functinal analysis of Glypican-1 in cancer stem-like cells and developmnt of antibody-based therapyPrincipal Investigator
- Principal Investigator
  
  Serada Satoshi
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Iwate Medical University
  Kochi University
Functional analysis of LSR and development of innovative therapy for ovarian cancer stem cells.
- Principal Investigator
  
  NAKA TETSUJI
- Project Period (FY)
  2016 – 2017
- Research Category
  
  Grant-in-Aid for Challenging Exploratory Research
- Research Field
  
  Tumor therapeutics
- Research Institution
  Kochi University
Development antibody-drug conjugate targeting glypican-1 for novel therapy of esophageal squamous cell carcinoma.Principal Investigator
- Principal Investigator
  
  SERADA Satoshi
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Tumor therapeutics
- Research Institution
  Kochi University
Proteomic screening for pancreatic cancer antigen and development of antibody-based medicine.Principal Investigator
- Principal Investigator
  
  SERADA SATOSHI
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Gastroenterology
- Research Institution
  National Institutes of Biomedical Innovation, Health and Nutrition
Proteomic screening for malignant melanoma antigen and development of antibody-based medicine for metastasis.
- Principal Investigator
  
  NAKA TETSUJI
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Challenging Exploratory Research
- Research Field
  
  Dermatology
- Research Institution
  National Institutes of Biomedical Innovation, Health and Nutrition
Functional analysis of Periostin in malignant melanomaPrincipal Investigator
- Principal Investigator
  
  SERADA Satoshi
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Dermatology
- Research Institution
  独立行政法人医薬基盤研究所
Development of cancer therapy using suppressor of cytokine signaling (SOCS) molecules.Principal Investigator
- Principal Investigator
  
  SERAD Satoshi
- Project Period (FY)
  2008 – 2009
- Research Category
  
  Grant-in-Aid for Young Scientists (Start-up)
- Research Field
  
  Urology
- Research Institution
  National Institute of Biomedical Innovation

[Book] サイトカインシグナル伝達抑制分子(SOCS)の新規抗癌剤としての応用2010
- Author(s)
  世良田聡,仲哲治
- Publisher
  医歯薬出版株式会社, 医学のあゆみ,234(5)
- Data Source
  KAKENHI-PROJECT-22791100
[Book] 医学のあゆみサイトカインシグナル伝達抑制分子(SOCS)の新規抗癌剤としての応用2010
- Author(s)
  世良田聡, 仲哲治
- Publisher
  医歯薬出版株式会社
- Data Source
  KAKENHI-PROJECT-22791100
[Journal Article] SOCS1 Gene Therapy for Head and Neck Cancers: An Experimental Study.2022
- Author(s)
  Kajiyama T, Serada S, Fujimoto M, Ohkawara T, Komori M, Hyodo M, Naka T.
- Journal Title
  
  Anticancer Res
  
  Volume: 42 Issue: 7 Pages: 3361-3372
- DOI
  10.21873/anticanres.15823
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K09694, KAKENHI-PROJECT-22K09728, KAKENHI-PROJECT-19K09848
[Journal Article] LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake2018
- Author(s)
  Hiramatsu K, Serada S, Enomoto T, Takahashi Y, Nakagawa S, Nojima S, Morimoto A, Matsuzaki S, Yokoyama T, Takahashi T, Fujimoto M, Takemori H, Ueda Y, Yoshino K, Morii E, Kimura T, Naka T
- Journal Title
  
  Cancer Res
  
  Volume: 78 Issue: 2 Pages: 516-27
- DOI
  10.1158/0008-5472.can-17-0910
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K11137, KAKENHI-PROJECT-17K11278, KAKENHI-PROJECT-17H04336, KAKENHI-PROJECT-15K08423, KAKENHI-PROJECT-16K14637
[Journal Article] Glypican-1 targeted antibody-based therapy induces preclinical antitumor activity against esophageal squamous cell carcinoma2017
- Author(s)
  Harada E, Serada S, Fujimoto M, Takahashi Y, Takahashi T, Hara H, Nakatsuka R, Sugase T, Nishigaki T, Saito Y, Hiramatsu K, Nojima S, Mitsuo R, Ohkawara T, Morii E, Mori M, Doki Y, Kaneda Y, Naka T.
- Journal Title
  
  Oncotarget.
  
  Volume: 8 Issue: 15 Pages: 24741-24752
- DOI
  10.18632/oncotarget.15799
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15K08423, KAKENHI-PROJECT-16K07193
[Journal Article] Anti-glypican-1 antibody-drug conjugate exhibits potent preclinical antitumor activity against glypican-1 positive uterine cervical cancer2017
- Author(s)
  Matsuzaki S, Serada S, Hiramatsu K, Nojima S, Matsuzaki S, Ueda Y, Ohkawara T, Mabuchi S, Fujimoto M, Morii E, Yoshino K, Kimura T, Naka T.
- Journal Title
  
  Int J Cancer.
  
  Volume: 142 Issue: 5 Pages: 1056-1066
- DOI
  10.1002/ijc.31124
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K08423, KAKENHI-PROJECT-16K07193
[Journal Article] Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma.2016
- Author(s)
  Hara, H., Takahashi, T., Serada, S., Fujimoto, M., Ohkawara, T., Nakatsuka, R., Harada, E., Nishigaki, T., Takahashi, Y., Nojima, S., Miyazaki, Y., Makino, T., Kurokawa, Y., Yamasaki, M., Miyata, H., Nakajima, K., Takiguchi, S., Morii, E., Mori, M., Doki, Y., Naka, T.
- Journal Title
  
  Br. J. Cancer.
  
  Volume: 115 Issue: 1 Pages: 66-75
- DOI
  10.1038/bjc.2016.183
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15H05791, KAKENHI-PROJECT-15K08423, KAKENHI-PROJECT-16K07193
[Journal Article] CpG ODN potentiates the anti-tumor activity of anti-BST2 antibody.2015
- Author(s)
  Hiramatsu, K., Serada, S., Kobiyama, K., Nakagawa, S., Morimoto, A., Matsuzaki, S., Ueda,Y., Fujimoto, M., Yoshino, K., Ishii, K., Enomoto, T., Kimura, T., Naka, T.
- Journal Title
  
  Cancer Science
  
  Volume: 106(10) Issue: 10 Pages: 474-82
- DOI
  10.1111/cas.12738
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15K15598, KAKENHI-PROJECT-25670508, KAKENHI-PROJECT-25860575, KAKENHI-PROJECT-25293338
[Journal Article] Suppressor of cytokine signalling-1 induces significant preclinical antitumor effect in malignant melanoma cells.2015
- Author(s)
  Tagami-Nagata N, Serada S, Fujimoto M, Tanemura A, Nakatsuka R, Ohkawara T, Murota H, Kishimoto T, Katayama I, Naka T.
- Journal Title
  
  Exp Dermatol.
  
  Volume: 24 Issue: 11 Pages: 864-71
- DOI
  10.1111/exd.12802
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K15418, KAKENHI-PROJECT-25670508, KAKENHI-PROJECT-25860575
[Journal Article] Leucine-rich α-2-glycoprotein promotes TGFβ1-mediated growth suppression in the Lewis lung carcinoma cell lines.2015
- Author(s)
  Takemoto N, Serada S, Fujimoto M, Honda H, Ohkawara T, Takahashi T, Nomura S, Inohara H, Naka T.
- Journal Title
  
  Oncotarget
  
  Volume: In Press
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-25670508
[Journal Article] Gene therapy with SOCS1 for gastric cancer induces G2/M arrest and has an anti-tumor effect on peritoneal carcinomatosis.2015
- Author(s)
  Natatsuka R, Takahashi T, Serada S,　Fujimoto M, Ookawara T, Nishida T, Hara H,　 Nishigaki T,　 Harada E,　Murakami T, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Miyata H,　Nakajima K, Takiguchi S, Kishimoto T, Mori M, Doki Y, Naka T.
- Journal Title
  
  Br J Cancer
  
  Volume: 113(3) Issue: 3 Pages: 433-442
- DOI
  10.1038/bjc.2015.229
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-26461700, KAKENHI-PROJECT-25670508, KAKENHI-PROJECT-25860575
[Journal Article] Proteomic identification of heterogeneous nuclear ribonucleoprotein K as a novel cold-associated autoantigen in patients with secondary Raynaud's phenomenon.2015
- Author(s)
  Yang L, Fujimoto M, Murota H, Serada S, Fujimoto M, Honda H, Yamada K, Suzuki K, Nishikawa A, Hosono Y, Yoneda Y, Takehara K, Imura Y, Mimori T, Takeuchi T, Katayama I, Naka T.
- Journal Title
  
  Rheumatology (Oxford).
  
  Volume: 54 Issue: 2 Pages: 349-58
- DOI
  10.1093/rheumatology/keu325
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24247036, KAKENHI-PLANNED-25116008, KAKENHI-PROJECT-25670508
[Journal Article] Annexin A4 induces platinum resistance in a chloride-and calcium-dependent manner.2014
- Author(s)
  Morimoto A, Serada S, Enomoto T, Kim A, Matsuzaki S, Takahashi T, Ueda Y, Yoshino K, Fujita M, Fujimoto M, Kimura T, Naka T.
- Journal Title
  
  Oncotarget
  
  Volume: 5 Pages: 7776-87
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-25670508
[Journal Article] Annexin A4 induces platinum resistance in a chloride-and calcium-dependent manner.2014
- Author(s)
  Morimoto A, Serada S, Enomoto T, Kim A, Matsuzaki S, Takahashi T, Ueda Y, Yoshino K, Fujita M, Fujimoto M, Kimura T, Naka T.
- Journal Title
  
  Oncotarget
  
  Volume: 5 Pages: 7776-87
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-25860575
[Journal Article] Screening for novel serum biomarker for monitoring disease activity in rheumatoid arthritis using iTRAQ technology-based quantitative proteomic approach.2014
- Author(s)
  Serada S, Naka T.
- Journal Title
  
  Methods Mol Biol.
  
  Volume: 1142 Pages: 99-110
- DOI
  10.1007/978-1-4939-0404-4_12
- ISBN
  9781493904037, 9781493904044
- Data Source
  KAKENHI-PROJECT-25860575
[Journal Article] Periostin accelerates human malignant melanoma progression by modificating the melanoma microenvironment2014
- Author(s)
  Kotobuki Y, Tanemura A, Serada S, Yang L, Nomura S, Kudo A, Izuhara K, Murota H, Fujimoto M, Katayama I, Naka T
- Journal Title
  
  Pigment Cell Melanoma Res
  
  Volume: 27 Issue: 4 Pages: 630-639
- DOI
  10.1111/pcmr.12245
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-25293224, KAKENHI-PROJECT-25670508
[Journal Article] Molecular mechanism underlying the antiproliferative effect of suppressor of cytokine signaling-1 in non-small-cell lung cancer cells.2013
- Author(s)
  Shimada K, Serada S, Fujimoto M, Nomura S, Nakatsuka R, Harada E, Iwahori K, Tachibana I, Takahashi T, Kumanogoh A, Kishimoto T, Naka T.
- Journal Title
  
  Cancer Sci.
  
  Volume: 104 Issue: 11 Pages: 1483-91
- DOI
  10.1111/cas.12266
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25670508, KAKENHI-PROJECT-25860575
[Journal Article] New findings of kinase switching in gastrointestinal stromal tumor under imatinib using phosphoproteomic analysis.2013
- Author(s)
  Takahashi T, Serada S, Ako M, Fujimoto M, Miyazaki Y, Nakatsuka R, Ikezoe T, Yokoyama A, Taguchi T, Shimada K, Kurokawa Y, Yamasaki M, Miyata H, Nakajima K, Takiguchi S, Mori M, Doki Y, Naka T, Nishida T.
- Journal Title
  
  Int J Cancer
  
  Volume: 133(11) Pages: 2737-2743
- DOI
  10.1002/ijc.28282
- Peer Reviewed
- Data Source
  KAKENHI-PLANNED-22130005, KAKENHI-PROJECT-25670508, KAKENHI-PROJECT-25860575
[Journal Article] D34(+) /CD38(-) acute myelogenous leukemia cells aberrantly express CD82 which regulates adhesion and survival of leukemia stem cells.2013
- Author(s)
  Nishioka C, Ikezoe T, Furihata M, Yang J, Serada S, Naka T, Nobumoto A, Kataoka S, Tsuda M, Udaka K, Yokoyama A
- Journal Title
  
  International Journal of Cancer
  
  Volume: 132(9) Issue: 9 Pages: 2006-2019
- DOI
  10.1002/ijc.27904
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24590412, KAKENHI-PROJECT-25670508, KAKENHI-PROJECT-25860575
[Journal Article] Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulceratiVe colitis2012
- Author(s)
  Serada S, Fujimoto M, Terabe F, Iijima H, Shinzaki S, Matsuzaki S, Ohkawara T, Nezu R, Nakajima S, Kobayashi T, Plevy SE, Takehara T, Naka T
- Journal Title
  
  Inflamm Bowel Dis
  
  Volume: 18(11) Pages: 2169-79
- Data Source
  KAKENHI-PROJECT-22791100
[Journal Article] Periostin Facilitates Skin Sclerosis via PI3K/Akt Dependent Mechanism in a Mouse Model of Scleroderma2012
- Author(s)
  Yang L, Serada S, Fujimoto M, Terao M, Kotobuki Y, Kitaba S, Matsui S, Kudo A, Naka T, Murota H, Katayama I
- Journal Title
  
  PLoS One
  
  Volume: 7(7)
- Data Source
  KAKENHI-PROJECT-22791100
[Journal Article] Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis2012
- Author(s)
  Serada S, Fujimoto M, Terabe F, Iijima H, Shinzaki S, Matsuzaki S, Ohkawara T, Nezu R, Nakajima S, Kobayashi T, Plevy SE, Takehara T, Naka T
- Journal Title
  
  Inflamm Bowel Dis
  
  Volume: (In Press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22791100
[Journal Article] Periostin Facilitates Skin Sclerosis via PI3K/Akt Dependent Mechanism in a Mouse Model of Scleroderma2012
- Author(s)
  Yang L, Serada S, Fujimoto M, Terao M, Kotobuki Y, Kitaba S, Matsui S, Kudo A, Naka T, Murota H, Katayama I
- Journal Title
  
  PLoS One
  
  Volume: 7(7) Issue: 7 Pages: e41994-e41994
- DOI
  10.1371/journal.pone.0041994
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591101, KAKENHI-PROJECT-22791100, KAKENHI-PROJECT-24659529, KAKENHI-PROJECT-24689045
[Journal Article] Anti-proliferative effect of SOCS-1 through the suppression of STAT3 and p38 MAPK activation in gastric cancer cells2012
- Author(s)
  Souma Y, Nishida T, Serada S, Iwahori K, Takahashi T, Fujimoto M, Ripley B, Nakajima K, Miyazaki Y, Mori M, Doki Y, Sawa Y, Naka T
- Journal Title
  
  Int J Cancer
  
  Volume: 131(6) Pages: 1287-96
- Data Source
  KAKENHI-PROJECT-22791100
[Journal Article] Dysregulation of Melanocyte Function by Th17-related Cytokines: Significance of Th17 Cell Infiltration in Autoimmune Vitiligo Vulgaris2012
- Author(s)
  Kotobuki Y, Tanemura A, Yang L, Itoi S, Kaneda M, Murota H, Fujimoto M, Serada S, Naka T Katayama I
- Journal Title
  
  Pigment Cell Melanoma Res
  
  Volume: 25(2) Pages: 219-30
- Data Source
  KAKENHI-PROJECT-22791100
[Journal Article] Periostin, a matricellular protein2012
- Author(s)
  Ontsuka K, Kotobuki Y, Shiraishi H, Serada S, Ohta S, Tanemura A, Yang L, Fujimoto M, Arima K, Suzuki S, Murota H, Toda S, Kudo A, Conway S, Narisawa Y, Katayama I, Izuhara K, Naka T
- Journal Title
  
  accelerates cutaneous wound repair by activating dermal fibroblasts Experimental Dermatology
  
  Volume: 21(5) Pages: 331-336
- Data Source
  KAKENHI-PROJECT-22791100
[Journal Article] Anti-proliferative effect of SOCS-1 through the suppression of STAT3 and p38 MAPK activation in gastric cancer cells2011
- Author(s)
  Souma Y, Nishida T, Serada S, Iwahori K, Takahashi T, Fujimoto M, Ripley B, Nakajima K, Miyazaki Y, Mori M, Doki Y, Sawa Y, Naka T
- Journal Title
  
  Int J Cancer
  
  Volume: (In Press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22791100
[Journal Article] Overexpression of SOCS3 exhibits preclinical antitumor activity against malignant pleural mesothelioma2011
- Author(s)
  Iwahori K, Serada S, Fujimoto M, Nomura S, Osaki T, Chun Man Lee, Mizuguchi H, Takahashi T, Ripley B, Okumura M, Kawase I, Kishimoto T, Naka T
- Journal Title
  
  International Journal of Cancer
  
  Volume: (In press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22791100
[Journal Article] Dysregulation of Melanocyte Function by Th17-related Cytokines : Significance of Th17 Cell Infiltration in Autoimmune Vitiligo Vulgaris2011
- Author(s)
  Kotobuki Y, Tanemura A, Yang L, Itoi S, Kaneda M, Murota H, Fujimoto M, Serada S, Naka T, Katayama I
- Journal Title
  
  Pigment Cell & Melanoma Research
  
  Volume: (In Press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22791100
[Journal Article] Blockade of Interleukin-6 Signaling Suppresses Not Only Th17 But Also Interphotoreceptor Retinoid Binding Protein-Specific Th1 By Promoting Regulatory T cells In Experimental Autoimmune Uveoretinitis2011
- Author(s)
  Haruta H, Ohguro N, Fujimoto M, Hohki S, Terabe F, Serada S, Nomura S, Nishida K, Kishimoto T, Naka T
- Journal Title
  
  Invest Ophthalmol Vis Sci
  
  Volume: 52 Pages: 3264-71
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22791100
[Journal Article] Blockade of Interleukin-6 Signaling Suppresses Not Only Th17 But Also Interphotoreceptor Retinoid Binding Protein-Specific Thl By Promoting Regulatory T cell In Experimental Autoimmune Uveoretinitis2011
- Author(s)
  Haruta H, Ohguro N, Fujimoto M, Hohki S, Terabe F, Serada S, Nomura S, Nishida K, Kishimoto T, Naka T
- Journal Title
  
  Invest Ophthalmol Vis Sci
  
  Volume: 52 Pages: 3264-71
- Data Source
  KAKENHI-PROJECT-22791100
[Journal Article] The Influence of Excessive IL-6 Production In Vivo on the Development and Function of Foxp3+ Regulatory T Cells.2011
- Author(s)
  Fujimoto M, Nakano M, Terabe F, Kawahata H, Ohkawara T, Han Y, Ripley B, Serada S, Nishikawa T, Kimura A, Nomura S, Kishimoto T, Naka T.
- Journal Title
  
  Journal of Immunology
  
  Volume: (In press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22791100
[Journal Article] The Influence of Excessive IL-6 Production In Vivo on the Development and Function of Foxp3+ Regulatory T Cells2011
- Author(s)
  Fujimoto M, Nakano M, Terabe F, Kawahata H, Ohkawara T, Han Y, Ripley B, Serada S, Nishikawa T, Kimura A, Nomura S, Kishimoto T, Naka T
- Journal Title
  
  J Immunol
  
  Volume: 186(1) Pages: 32-40
- Data Source
  KAKENHI-PROJECT-22791100
[Journal Article] Comparative analysis of the effects of anti-IL-6 receptor mAb and anti-TNF mAb treatment on CD4+ T-cell responses in murine colitis2011
- Author(s)
  Terabe F, Fujimoto M, Serada S, Shinzaki S, Iijima H, Tsujii M, Hayashi N, Nomura S, Kawahata H, Myoung Ho Jang, Miyasaka M, Mihara M, Ohsugi Y, Kishimoto T, Naka T
- Journal Title
  
  Inflamm Bowel Dis
  
  Volume: 17(2) Pages: 491-502
- Data Source
  KAKENHI-PROJECT-22791100
[Journal Article] Comparative analysis of the effects of anti-IL-6 receptor mAb and anti-TNF mAb treatment on CD4+ T-cell responses in murine colitis2011
- Author(s)
  Terabe F, Fujimoto M, Serada S, Shinzaki S, Iijima H, Tsujii M, Hayashi N, Nomura S, Kawahata H, Myoung Ho Jang, Miyasaka M, Mihara M, Ohsugi Y, Kishimoto T, Naka T
- Journal Title
  
  Inflammatory Bowel Diseases
  
  Volume: 17 Pages: 491-502
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22791100
[Journal Article] Overexpression of SOCS3 exhibits preclinical antitunlor activity against malignant pleural mesothelioma2011
- Author(s)
  Iwahori K, Serada S, Fujimoto M, Nomura S, Osaki T, Chun Man Lee, Mizuguchi H, Takahashi T, Ripley B, Okumura M, Kawase I, Kishimoto T, Naka T
- Journal Title
  
  Int J Cancer
  
  Volume: 129(4) Pages: 1005-17
- Data Source
  KAKENHI-PROJECT-22791100
[Journal Article] Blockade of Interleukin-6 Signaling SupPresses Experimental Autoimmune Uveoretinitis by the Inhibition of Inflammatory Th17 Responses2010
- Author(s)
  Hohki S, Ohguro N, Haruta H, Nakai K, Terabe F, Serada S, Fujimoto M, Nomura S, Kawahata H, Kishimoto T, Naka T
- Journal Title
  
  Exp Eye Res
  
  Volume: 91(2) Pages: 162-70
- Data Source
  KAKENHI-PROJECT-22791100
[Journal Article] iTRAQ-based proteomic identification of leucine rich alpha 2 glycoprotein(LRG)as a novel inflammatory biomarker in autoimmune diseases2010
- Author(s)
  Serada S
- Journal Title
  
  Ann Rheum Dis 69
  
  Pages: 770-774
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20890302
[Journal Article] iTRAQ-based proteomic identification of leucine rich alpha 2 glycoprotein (LRG) as a novel inflammatory biomarker in autoimmune diseases2010
- Author(s)
  Serada S, Fujimoto M, Ogata A, Terabe F, Hirano T, Iijima H, Shinzaki S, Nishikawa T, Ohkawara T, Iwahori K, Ohguro N, Kishimoto T, Naka T
- Journal Title
  
  Ann Rheum Dis
  
  Volume: 69 Pages: 770-774
- Data Source
  KAKENHI-PROJECT-22791100
[Journal Article] Blockade of Interleukin-6 Signaling Suppresses Experimental Autoimmune Uveoretinitis by the Inhibition of Inflammatory Th17 Responses.2010
- Author(s)
  Hohki S, Ohguro N, Haruta H, Nakai K, Terabe F, Serada S, Fujimoto M, Nomura S, Kawahata H, Kishimoto T, Naka T.
- Journal Title
  
  Experimental Eye Research.
  
  Volume: 91 Pages: 162-170
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22791100
[Journal Article] iTRAQ-based proteomic identification of leucine rich alpha 2 glycoprotein (LRG) as a novel inflammatory biomarker in autoimmune diseases2010
- Author(s)
  Serada S, Fujimoto M, Ogata A, Terabe F, Hirano T, Iijima H, Shinzaki S, Nishikawa T, Ohkawara T, Iwahori K, Ohguro N, Kishimoto T, Naka T
- Journal Title
  
  Annals of the Rheumatic Diseases
  
  Volume: 69 Pages: 770-774
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22791100
[Journal Article] Enhanced expression of Annexin A4 in clear cell carcinoma of the ovary and its association with chemoresistance to carboplatin2009
- Author(s)
  Kim A, Enomoto T, Serada S, Naka T, et al.(13人中3番目)
- Journal Title
  
  International Journal of Cancer 125(10)
  
  Pages: 2316-22
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20890302
[Journal Article] iTRAQ-based proteomic identification of leucine rich alpha 2 glycoprotein (LRG) as a novel inflammatory biomarker in autoimmune diseases2009
- Author(s)
  Serada S, Naka T, et al.(13人中1番目)
- Journal Title
  
  Ann Rheum Dis (In Press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20890302
[Journal Article] Megakaryocyte potentiating factor as a tumor marker of malignant pleural mesothelioma: Evaluation in comparison with mesothelin2008
- Author(s)
  Iwahori K, Osaki T, Serada S, Fujimoto M, Naka T, et al.(16人中3番目)
- Journal Title
  
  Lung Cancer 62(1)
  
  Pages: 45-54
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20890302
[Journal Article] Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses2008
- Author(s)
  Fujimoto M, Serada S, Naka T, et al.(13人中3番目)
- Journal Title
  
  Arthritis Rheum 58
  
  Pages: 3710-3719
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20890302
[Journal Article] IL-6 blockade inhibits the induction of myelin antigen specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis2008
- Author(s)
  Serada S
- Journal Title
  
  Proc Natl Acad Sci USA. 105
  
  Pages: 9041-9046
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20890302
[Journal Article] Aberrant Expression of Glycosylation in Juvenile Gastrointestinal Stromal Tumors2008
- Author(s)
  Takahashi T, Naka T, Fujimoto M, Serada S, Nishida T, et al.(14人中4番目)
- Journal Title
  
  Proteomics clinical applications 2
  
  Pages: 1246-1254
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20890302
[Journal Article] ranscriptional Complex Formation of c-Fos, STAT3, and HNF-1a is Essential for Cytokine-Driven CRP Gene Expression2008
- Author(s)
  Nishikawa T, Hagihara K, Serada S, Naka T, Yoshizaki K, et al.(10人中3番目)
- Journal Title
  
  Journal of Immunology 180(5)
  
  Pages: 3492-501
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20890302
[Journal Article] IL-6 blockade inhibits the induction of myelin antigen specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis2008
- Author(s)
  Serada S, Fujimoto M, Kishimoto T, Naka T, et al.(15人中1番目)
- Journal Title
  
  Proc Natl Acad Sci U S A 105(26)
  
  Pages: 9041-6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20890302
[Journal Article] Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice2008
- Author(s)
  Horino J, Fujimoto M, Terabe F, Serada S, Kishimoto T, Naka T, et al.(14人中4番目)
- Journal Title
  
  Int Immunol 6
  
  Pages: 753-62
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20890302
[Journal Article]2008
- Author(s)
  世良田聡
- Journal Title
  
  実験医学(羊土社)
  
  Pages: 3062-3065
- Data Source
  KAKENHI-PROJECT-20890302
[Patent] 抗ＧＰＣ－１抗体2018
- Inventor(s)
  仲哲治、世良田聡、藤本穣
- Industrial Property Rights Holder
  国立大学法人高知大学
- Industrial Property Rights Type
  特許
- Filing Date
  2018
- Overseas
- Data Source
  KAKENHI-PROJECT-16K07193
[Patent] 抗ＧＰＣ－１抗体2017
- Inventor(s)
  仲哲治、世良田聡、藤本穣
- Industrial Property Rights Holder
  国立大学法人高知大学
- Industrial Property Rights Type
  特許
- Industrial Property Number
  2017-090054
- Filing Date
  2017
- Data Source
  KAKENHI-PROJECT-16K07193
[Patent] 創傷治癒剤2010
- Inventor(s)
  寿順久、世良田聡、仲哲治
- Industrial Property Rights Holder
  財団法人ヒューマンサイエンス振興財団
- Industrial Property Number
  2010-151139
- Filing Date
  2010-07-01
- Data Source
  KAKENHI-PROJECT-22791100
[Patent] 創傷治癒剤2010
- Inventor(s)
  寿順久、世良田聡、仲哲治
- Industrial Property Rights Holder
  財団法人ヒューマンサイエンス振興財団
- Industrial Property Number
  2010-151139
- Filing Date
  2010-07-01
- Data Source
  KAKENHI-PROJECT-22791100
[Patent] SOCS活性化剤を有効成分とする抗癌剤2008
- Inventor(s)
  仲哲治、世良田聡、岩堀幸太、藤本穰
- Industrial Property Rights Holder
  財団法人ヒューマンサイエンス振興財団
- Industrial Property Number
  2008-301919
- Filing Date
  2008-11-27
- Data Source
  KAKENHI-PROJECT-20890302
[Patent] SOCS活性化剤を有効成分とする抗癌剤2008
- Inventor(s)
  仲哲治, 世良田聡, 岩掘幸太, 藤本穰
- Industrial Property Rights Holder
  財団法人ヒューマンサイエンス振興財団
- Industrial Property Number
  2008-301919
- Filing Date
  2008-11-27
- Data Source
  KAKENHI-PROJECT-20890302
[Presentation] Anti-glypican-1(GPC-1)-CAR-T cells can completely eradicate established solid tumor without adverse effects2018
- Author(s)
  Yaguchi T, Kato D, Morii K, Serada S, Naka T, Kawakami Y.
- Organizer
  11th AACR-JCA Joint Conference on Breakthroughs in Cancer Research: Biology to Precision Medicine.
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K07193
[Presentation] Anti - glypican-1 (GPC-1) - CAR-T cells can completely eradicate established solid tumor without adverse effects.2018
- Author(s)
  Kato D, Yaguchi T, Morii K, Serada S, Naka T, Nakagawa T, Nishimura R, Kawakami Y.
- Organizer
  第47回日本免疫学会学術集会
- Data Source
  KAKENHI-PROJECT-16K07193
[Presentation] 膵癌に対する抗Glypican-1抗体薬物複合体による新規治療法の開発2017
- Author(s)
  西垣貴彦、高橋剛、世良田聡、田中晃司、宮崎安弘、牧野知紀、黒川幸典、山﨑誠、中島清一、滝口修司、森正樹、土岐祐一郎、仲哲治
- Organizer
  第26回日本がん転移学会学術集会・総会
- Data Source
  KAKENHI-PROJECT-16K07193
[Presentation] LSR promotes ovarian cancer cell growth following the activation of β-oxidation and its antibody inhibits lipid catabolism. ポスター発表(英語)2017
- Author(s)
  Hiramatsu K, Serada S, Enomoto T, Yokoyama T, Takahashi Y, Fujimoto M, Yoshino K, Kimura T, Naka T.
- Organizer
  AACR Annual Meeting 2017 in Washington, D.C
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K14637
[Presentation] LSR promotes beta-oxidation via lipid uptake and subsequent tumor growth in ovarian cancer.口頭発表(英語)2017
- Author(s)
  Hiramatsu K, Serada S, Fujimoto M, Matsuzaki S, Ueda Y, Yoshino K, Kimura T, Naka T.
- Organizer
  第76回日本癌学会学術総会パシフィコ横浜
- Data Source
  KAKENHI-PROJECT-16K14637
[Presentation] Heterogeneous Nuclear RNP-K Is a Novel Cold-Related Autoantigen in Patients with Raynaud' s Phenomenon2012
- Author(s)
  Satoshi Serada, Minoru Fujimoto, Tetsuji Naka
- Organizer
  ACR/ARHP Annual Meeting, in Washington, DC, November 09-14, 2012. November 12 (ACR 2012第78回米国リウマチ学会議)
- Place of Presentation
  米国(ワシントン)
- Data Source
  KAKENHI-PROJECT-22791100
[Presentation] 定量的リン酸化プロテオーム解析による消化管間質腫瘍のイマチニブ耐性因子の探索2012
- Author(s)
  世良田聡,高橋剛,浦瀬真伊子,藤本穣,原田絵美,西田俊朗,仲哲治
- Organizer
  第10回日本ヒトプロテオーム学会
- Place of Presentation
  本科学未来館7階(東京)
- Data Source
  KAKENHI-PROJECT-22791100
[Presentation] Quantitative proteomic analysis of tumor growth associated proteins in cutaneous malignant melanoma Short title: Proteomics of melanoma2012
- Author(s)
  Satoshi Serada, Yorihisa Kotobuki, Atsushi Tanemura, Ichiro Katayama, Tetsuji Naka
- Organizer
  103rd Annual Meeting of the American Association for Cancer Research;2012
- Place of Presentation
  米国(シカゴ)
- Year and Date
  2012-04-02
- Data Source
  KAKENHI-PROJECT-22791100
[Presentation] Periostin, a matricellular protein, accelerates wound repair by activating dermal fibroblasts2011
- Author(s)
  Yorihisa Kotobuki, Kanako Ontsuka, Satoshi Serada, Hiroshi Shiraishi, Atsushi Tanemura, Shoichiro Ohta, Lingli Yang, Tetsuji Naka, Kenji Izuhara, Ichiro Katayama
- Organizer
  第36回日本研究皮膚科学会学術大会・総会
- Place of Presentation
  国立京都国際会館(京都市)
- Data Source
  KAKENHI-PROJECT-22791100
[Presentation] 定量的プロテオーム解析による子宮内膜癌抗原蛋白質の探索2011
- Author(s)
  世良田聡,横山拓平,榎本隆之,松崎慎哉,森本晶子,金雅子,藤本穣,木村正,仲哲治
- Organizer
  第9回日本プロテオーム学会
- Place of Presentation
  新潟市朱鷺メッセ2階(新潟市)
- Data Source
  KAKENHI-PROJECT-22791100
[Presentation] Leucine rich alpha 2 glycoprotein (LRG) is a novel biomarker for monitoring disease activity in patients with Ulcerative Colitis2011
- Author(s)
  Satoshi Serada, Minoru Fujimoto, Fumitaka Terabe, Tetsuji Naka
- Organizer
  第40回日本免疫学会総会
- Place of Presentation
  幕張メッセ(千葉市)
- Data Source
  KAKENHI-PROJECT-22791100
[Presentation] Periostin, a matricellular protein, accelerates wound repair by activating dermal fibroblasts2011
- Author(s)
  Yorihisa Kotobuki, Kanako Ontsuka, Satoshi Serada, Hiroshi Shiraishi, Atsushi Tanemura, Shoichiro Ohta, Lingli Yang, Tetsuji Naka, Kenji Izuhara, Ichiro Katayama
- Organizer
  第36回日本研究皮膚科学会学術大会・総会
- Place of Presentation
  国立京都国際会館
- Year and Date
  2011-12-09
- Data Source
  KAKENHI-PROJECT-22791100
[Presentation] 定量的プロテオーム解析による子宮内膜癌抗原蛋白質の探索2011
- Author(s)
  Satoshi Serada, Takuhei Yokoyama, Takayuki Enomoto, Shinya Matsuzaki, Akiko Morimoto, Ayako Kim, Minoru Fujimoto, Tadashi Kimura, Tetsuji Naka
- Organizer
  第9回日本プロテオーム学会
- Place of Presentation
  新潟市朱鷺メッセ
- Year and Date
  2011-07-29
- Data Source
  KAKENHI-PROJECT-22791100
[Presentation] lLabotatory For Immune Signal, National Institute of Biomedical Innovation, Ibaraki City (Osaka)/JAPAN, 2 Surgery, Osaka University, Suita/JAPAN, 3 Surgery, Osaka Police Hospital, Osaka/JAPAN, 4 Laboratory For Immune Signal, National Institute of Biomedical Innovation, Ibaraki City (Osaka)/JAPAN2010
- Author(s)
  S. Serada, Y. Souma, T. Nishida, M. Fujimoto, T. Naka
- Organizer
  SOCS-1,-3 GENE DELIVERY IN GASTRIC CANCER CELLS INDUCES A POTENT ANTI-PROLIFERATIVE EFFECT VIA THE SUPPRESSION OF JAK/STAT AND P38 MAPK S IGNAL ING PATHWAYS
- Place of Presentation
  イタリア(ミラノ)
- Year and Date
  2010-10-09
- Data Source
  KAKENHI-PROJECT-22791100
[Presentation] 自己免疫疾患の新規活動性マーカーとしてのleucine rich alpha 2 glycoprotein2010
- Author(s)
  世良田聡、藤本穣、寺部文隆、西川哲平、仲哲治
- Organizer
  第8回日本プロテオーム学会
- Place of Presentation
  東京ベイホテル東急(浦安市)
- Data Source
  KAKENHI-PROJECT-22791100
[Presentation] SOCS-1,-3 GENE DELIVERY IN GASTRIC CANCER CELLS INDUCES A POTENT ANTI-PROLIFERATIVE EFFECT VIA THE SUPPRESSION OF JAK/STAT AND P38 MAPK SIGNALING PATHWAYS2010
- Author(s)
  Serada S, Souma Y, Nishida T, Fujimoto M, Naka T
- Organizer
  35th ESMO Congress
- Place of Presentation
  イタリア(ミラノ)
- Year and Date
  2010-10-09
- Data Source
  KAKENHI-PROJECT-22791100
[Presentation] 自己免疫疾患の新規活動性マーカーとしてのleucine rich alpha 2 glycoprotein Proteomics-based identification of leucine rich alpha 2 glycoprotein(LRG)as a novel biomarker associated with disease activity of inflammatory autoimmune disorders2010
- Author(s)
  世良田聡、藤本穣、寺部文隆、西川哲平、仲哲治
- Organizer
  第8回日本プロテオーム学会
- Place of Presentation
  千葉
- Year and Date
  2010-07-26
- Data Source
  KAKENHI-PROJECT-22791100
[Presentation] Anti-proliferative effect of SOCS-1, -3 through the suppression of JAK/STAT and P38 MAPK signaling pathways in gastric cancer cells2009
- Author(s)
  Souma Y, Serada S, Naka T., et al (7人中4番目)
- Organizer
  ECCO 15 - 34th ESMO Multidisciplinary Congress Internationale Congress Centrum Berlin (ICC Berlin)
- Place of Presentation
  Berlin
- Data Source
  KAKENHI-PROJECT-20890302
[Presentation] Proteomics-based identification of leucine rich alpha 2 glycoprotein(LRG)as a novel biomarker associated with disease activity of inflammatory autoimmune disorders2009
- Author(s)
  Serada S
- Organizer
  日本免疫学会
- Place of Presentation
  大阪
- Year and Date
  2009-12-04
- Data Source
  KAKENHI-PROJECT-20890302
[Presentation] SOCS-3 protein exhibits potent anti-tumor activity in malignant pleural mesothelioma2009
- Author(s)
  Iwahori K, Serada S, Naka T., et al (5人中2番目)
- Organizer
  13th World Conference on Lung Cancer
- Place of Presentation
  San Francisco, California, USA
- Data Source
  KAKENHI-PROJECT-20890302
[Presentation] Megakaryocyte potentiating factor is a more effective marker for the differential diagnosis of malignant pleural mesothelioma compared with mesothelin.2009
- Author(s)
  Serada S
- Organizer
  13th World Conference on Lung Cancer
- Place of Presentation
  San Francisco,, USA
- Year and Date
  2009-08-02
- Data Source
  KAKENHI-PROJECT-20890302
[Presentation] Identification of alpha-enolase autoantibody as a novel biomarker in non-small cell lung cancer2008
- Author(s)
  Serada S
- Organizer
  20^<th> EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
- Place of Presentation
  Geneva, Switzerland
- Data Source
  KAKENHI-PROJECT-20890302
[Presentation] Proteomics-based identification of leucine rich alpha 2 glycoprotein (LRG) as a novel biomarker associated with disease activity of inflammatory autoimmune disorders
- Author(s)
  Serada S, Naka T., et al (6人中1番目)
- Organizer
  第39回日本免疫学会総会
- Place of Presentation
  大阪
- Data Source
  KAKENHI-PROJECT-20890302
[Presentation] Quantitative proteomic analysis of tumor growth associated proteins in cutaneous malignant melanoma
- Author(s)
  Serada　S, Kotobuki Y, Tanemura A, Katayama I, Naka T
- Organizer
  103rd Annual Meeting of the American Association for Cancer Research
- Place of Presentation
  米国（シカゴ）
- Data Source
  KAKENHI-PROJECT-22791100
[]

1. NAKA TETSUJI (30303936)

# of Collaborated Projects: 5 results

# of Collaborated Products: 7 results
2. FUJIMOTO MINORU (00379190)

# of Collaborated Projects: 3 results

# of Collaborated Products: 5 results
3. YOSHINO KIYOSHI (90362730)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
4. Komori Masahiro (30565742)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
5. 兵頭政光 (00181123)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
6. 梶山泰平 (60807931)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
7. 神田瑞希 (10935406)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. 外舘玄一朗 (70405819)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. 赤坂真奈美 (00405797)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
10. TSUJII Shigehiro

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
11. 野島聡

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
12. 上田豊

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
13. 松崎慎哉

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
14. 榎本隆之

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
15. 森正樹

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
16. 片山一朗

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
17. 出原賢治

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
18. 村上孝

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
19. 降幡睦夫

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
20. 米田悦啓

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
21. 土岐祐一郎

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

SERADA Satoshi 世良田 聡

SERAD Satoshi 世良田 聡

SERADA SATOSHI 世良 田聡

Research Projects

Research Products

Co-Researchers

Glypican-1を標的とした新規抗体薬物複合体による化学療法抵抗性膵臓癌の克服Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

プロテオーム解析による、重症気管支肺異形成を予測する新規バイオマーカーの同定

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of a companion diagnostics toward for Glypican-1 targeted antibody-based medicinePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

抗癌剤の薬効を増強できる抗体を用いた抗体薬物複合体による卵巣癌治療薬

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

An Experimental Stady for SOCS1 Gene Therapy in Head and Neck Cancers treatments

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Functinal analysis of Glypican-1 in cancer stem-like cells and developmnt of antibody-based therapyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Functional analysis of LSR and development of innovative therapy for ovarian cancer stem cells.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development antibody-drug conjugate targeting glypican-1 for novel therapy of esophageal squamous cell carcinoma.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Proteomic screening for pancreatic cancer antigen and development of antibody-based medicine.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Proteomic screening for malignant melanoma antigen and development of antibody-based medicine for metastasis.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Functional analysis of Periostin in malignant melanomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of cancer therapy using suppressor of cytokine signaling (SOCS) molecules.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] サイトカインシグナル伝達抑制分子(SOCS)の新規抗癌剤としての応用2010

Author(s)

SERADA Satoshi 世良田聡

SERAD Satoshi 世良田聡

SERADA SATOSHI 世良田聡